Compare Novavax Inc (NVAX) vs Palantir Technologies Inc (PLTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Palantir Technologies Inc — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Palantir Technologies Inc trades at $132.01 (market cap $323.28B). The key difference: Palantir Technologies Inc is far larger — about 248.7× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Palantir Technologies Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | PLTR | |
|---|---|---|
Market Cap | $1.30B | $323.28B |
Sector | Health | Technology |
52-Week High | $11.19 | $207.18 |
52-Week Low | $6.22 | $107.27 |
Enterprise Value | $800.50M | $315.46B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Palantir Technologies Inc
Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.
Read more on PLTR →
